Sex differences in gout epidemiology: Evaluation and treatment

Annals of the Rheumatic Diseases

Volumn 65, Issue 10, 2006, Pages 1368-1372

  Harrold, L R ^a,b   Yood, R A ^b   Mikuls, T R ^c   Andrade, S E ^b   Davis, J ^b   Fuller, J ^b   Chan, K A ^d   Roblin, D ^e   Raebel, M A ^e   Von Worley, A ^f   Platt, R ^g   Saag, K G ^h  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e KAISER PERMANENTE   (United States)

^f LOVELACE CLINIC FOUNDATION   (United States)

^g HARVARD PILGRIM HEALTH CARE   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; COLCHICINE; DIURETIC AGENT; GLUCOCORTICOID; LOOP DIURETIC AGENT; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; POTASSIUM SPARING DIURETIC AGENT; SALICYLIC ACID; THIAZIDE DIURETIC AGENT; URATE; URICOSURIC AGENT;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; GOUT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED STATES; URIC ACID BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DIURETICS; DRUG MONITORING; DRUG UTILIZATION; EPIDEMIOLOGIC METHODS; FEMALE; GOUT; GOUT SUPPRESSANTS; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; UNITED STATES; URIC ACID;

EID: 33750396847     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.051649     Document Type: Article

References (22)

1. Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC. The association between gout and nephrolithiasis in men: the health professionals' follow-up study. Kidney Int 2003;64:1022-6.
2. Lally EV, Ho G Jr, Kaplan SR. The clinical spectrum of gouty arthritis in women. Arch Intern Med 1986;146:2221-5.
3. Puig JG, Michan AD, Jimenez ML, Perez de Ayala C, Mateos FA, Capitan CF, et al. Female gout. Clinical spectrum and uric acid metabolism. Arch Intern Med 1991;151:726-32.
4. Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005;165:742-8.
5. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004;363:1277-81.
6. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093-103.
7. Agudelo C, Wise C. Crystal-associated arthritis. Clin Geriatr Med 1998;14:495-513.
8. Rolt KT, Agudelo CA. Gout. JAMA 2003;289:2857-60.
9. Terkeltaub RA. Gout: Epidemiology, pathology and pathogenesis. In: Klippel JH, Crofford L, Stone JH, et al. Primer on the rheumatic disease. 12th edn. Atlanta: Arthritis Foundation, 2001:307-12.
10. Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31:1582-7.
11. ALLHAT officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000;283:1967-75.
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-72.
13. Lin KC, Lin HY, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 2000;27:1501-5.
14. St Onge MP, Keller KL, Heymsfield SB. Changes in childhood food consumption patterns: a cause for concern in light of increasing body weights. Am J Clin Nutr 2003;78:1068-73.
15. Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004;50:2400-14.
16. Reyes D, Lew SQ, Kimmel PL. Gender differences in hypertension and kidney disease. Med Clin North Am 2005;89:613-30.
17. Meyers OL, Monteagudo FS. A comparison of gout in men and women. A 10-year experience. S Afr Med J 1986;70:721-3.
18. Platt R, Davis R, Finkelstein J, Go AS, Gurwitz JH, Roblin D, et al. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf 2001;10:373-7.
19. Chan KA. Development of a multipurpose dataset to evaluate potential medication errors in ambulatory setting. In: Henriksen K, Battles JB, Marks ES, Lewin DI, eds. Advances in patient safety:from research to implementation. Vol 2. Rockviile, MD: Agency for Healthcare Research and Quality, 2005.
20. Mikuls TR, MacLean CH, Olivieri JJ, Patino F, Allison JJ, Farrar JT, et al. Quality of care indicators in gout management. Arthritis Rheum 2004;50:937-43.
21. Souza AWS, Fernandes V, Ferrari AJL. Female gout: clinical and laboratory features. J Rheumatol 2005;32:2186-8.
22. National Center for Health Statistics. Health, United States 2004 with chartbook on trends in the health of Americans. Hyattsville, MD: 2004, (Health maintenance organizations (HMOs) and enrollment, according to model type, geographic region, and federal program. USA: 1976-2003).http://www.cdc.gov/nchs/ data/hus/hus04trend.pdf#tables (accessed 18 Nov 2005).